Gabelli Healthcare & WellnessRx Trust (GRX) had a reported purchase of 1,056 common shares at $10.21 per share on November 18, 2026. The securities were held by funds and accounts for which Saba Capital Management, L.P., a ten percent owner, serves as investment manager; those holdings totaled 2,197,294 shares after the purchase. No Rule 10b5-1 plan is reported.
Saba Capital Management, L.P., a 10% owner of Gabelli Healthcare & WellnessRx Trust (GRX), reported an indirect purchase of 200 common shares on November 16, 2026, at $10.40 per share. The shares were held by funds and/or accounts for which Saba Capital serves as investment manager; the reported resulting position was 2,196,238 shares. No Rule 10b5-1 plan is reported.
Gabelli Healthcare & WellnessRx Trust (GRX) reported that Saba Capital Management, L.P., identified as a 10% owner, purchased 300 common shares on November 13, 2026, at $10.40 per share. The shares are held by funds and/or accounts for which Saba Capital Management serves as investment manager. The reported resulting indirect position was 2,196,038 shares. No Rule 10b5-1 plan is reported.
Gabelli Healthcare & WellnessRx Trust (GRX) reported an indirect purchase of 8,916 common shares on November 5, 2026, at $10.44 per share. Saba Capital Management, L.P., identified as a 10% owner, serves as investment manager for the funds and/or accounts holding the shares; those funds and accounts reported 2,195,738 shares following the purchase. No Rule 10b5-1 plan is reported.
Gabelli Healthcare & WellnessRx Trust (GRX) reported an indirect purchase of 700 shares by funds and accounts for which Saba Capital Management, L.P., a ten percent owner, serves as investment manager. The purchase was reported on November 4, 2026, at $10.4300 per share; the post-transaction holding was reported as 2,186,822 shares. No Rule 10b5-1 plan is reported.
Gabelli Healthcare & WellnessRx Trust (GRX) common stock was purchased indirectly by funds and/or accounts for which Saba Capital Management, L.P., a 10% owner, serves as investment manager: 100 shares at $10.18 per share on November 3, 2026. The reported indirect holdings following the transaction were 2,186,122 shares. Boaz R. Weinstein serves as the managing member of Saba Capital Management GP, LLC, the general partner of Saba Capital Management, L.P.; no Rule 10b5-1 plan is reported.
Funds and accounts managed by Saba Capital Management, L.P., a ten percent owner of Gabelli Healthcare & WellnessRx Trust (GRX), purchased 1,201 common shares on November 2, 2026, at $10.15 per share. The reported resulting position was 2,186,022 shares. No Rule 10b5-1 plan is reported.
Gabelli Healthcare & WellnessRx Trust (GRX) reported that Saba Capital Management, L.P., a ten percent owner, made an indirect purchase of 10,196 common shares on October 30, 2026, at $10.13 per share. The securities are held by funds and/or accounts for which Saba Capital Management, L.P. serves as investment manager. The reported position after the purchase was 2,184,821 common shares. The purchase was not reported under a Rule 10b5-1 plan.
Gabelli Healthcare & WellnessRx Trust (GRX) reported that funds and/or accounts for which ten percent owner Saba Capital Management, L.P. serves as investment manager purchased 500 shares on October 29, 2026, at $10.09 per share. The purchase was reported as indirect, with reported holdings of 2,174,625 shares following the transaction. Boaz R. Weinstein is identified as managing member of Saba Capital Management GP, LLC, the general partner of Saba Capital Management, L.P. No Rule 10b5-1 plan is reported.
Gabelli Healthcare & WellnessRx Trust (GRX) reported that funds and accounts for which Saba Capital Management, L.P., a ten percent owner, serves as investment manager purchased 300 common shares on October 27, 2026, at $9.99 per share. The reported resulting holdings were 2,174,125 shares. No Rule 10b5-1 plan is reported for the purchase.